42
total announcements
EMCURE.NS · 15 min delayed
Key Stats · Yahoo Finance · as of 15 Oct 2026
Market Cap
₹35,404 Cr
P/E (TTM)
35.0
P/E (Forward)
24.0
EPS (TTM)
₹53.35
52W Low
₹1,306.50
52W High
₹2,100.70
Dividend Yield
0.19%
Beta
-0.08
Price / Book
7.1
Debt / Equity
30.6
Revenue (TTM)
₹9,683 Cr
Gross Margin
59.43%
Operating Margin
15.44%
Emcure Pharmaceuticals Limited
Emcure Pharmaceuticals Limited disclosed under SEBI Takeover Regulations that except for Smita Paresh Shah's pledge of 60,000 equity shares, there are no encumbrances on the equity shares held by promoters during the FY ended March 31, 2026.
Emcure Pharmaceuticals Limited
Emcure Pharmaceuticals Limited announced the allotment of 20,600 equity shares on June 19, 2026. These shares, each with a face value of Rs. 10, were issued pursuant to the exercise of Employee Stock Options (ESOPs) under the company's 2013 scheme. The Nomination and Remuneration Committee approved this allotment. This action serves to incentivize employees, leading to a minor dilution in the existing shareholding base.